COCP – cocrystal pharma, inc. (US:NASDAQ)
Stock Stats
News
11/13
08:00 am
cocp
Low
Cocrystal Pharma Reports Third Quarter 2024 Financial Results and Provides Updates on its Antiviral Drug-Development Programs
10/31
08:00 am
cocp
Low
Cocrystal Pharma’s Co-CEOs Highlight Pioneering Approach to Antiviral Drug Candidates Targeting Influenza and Coronaviruses as Fall Flu and COVID Season Begins
10/18
07:18 am
cocp
Low
Here's Why We're Watching Cocrystal Pharma's (NASDAQ:COCP) Cash Burn Situation [Yahoo! Finance]
11/13/2024
08:00 am
cocp
1.7%
BEAT
8/14/2024
08:00 am
cocp
-10.5%
MISS
11/13
03:30 pm
cocp
Neutral
Form 8-K Cocrystal Pharma, Inc. For: Nov 13
11/13
08:31 am
cocp
Low
Form 10-Q Cocrystal Pharma, Inc. For: Sep 30
10/31
09:10 am
cocp
Low
Form 8-K Cocrystal Pharma, Inc. For: Oct 31
10/11
04:07 pm
cocp
Low
Form 4 Cocrystal Pharma, Inc. For: Oct 09 Filed by: FROST PHILLIP MD ET AL
10/11
04:07 pm
cocp
Low
Form 4 Cocrystal Pharma, Inc. For: Oct 09 Filed by: Kornberg Roger D.
Show more
Top News Gainers
2/24 Cocrystal Pharma, Inc. Announces License Agreement with Kansas State University Research Foundation for Norovirus and Coronavirus Antiviral Compounds 129.3%
3/6 Cocrystal Pharma Announces Plans to Advance Coronavirus Program 18.6%
10/16 Is Cocrystal Pharma, Inc. (NASDAQ:COCP) Overpaying Its CEO? [Yahoo! Finance News] 14.5%
3/11 Cocrystal Pharma Announces Closing of $6.8 Million Registered Direct Offering Priced At-the-Market 11.5%
1/31 Form 8-K Cocrystal Pharma, Inc. For: Jan 29 10.0%
2/27 Form SC 13G Cocrystal Pharma, Inc. Filed by: SABBY MANAGEMENT, LLC 9.4%
2/28 Cocrystal Pharma Announces Closing of $11.0 Million Registered Direct Offering Priced At-the-Market 8.6%
10/29 Form 4 Cocrystal Pharma, Inc. For: Oct 23 Filed by: Schinazi Raymond F 7.5%
4/15 Cocrystal Pharma to Present at the April 2020 Virtual Investor Summit 7.5%
2/18 Form 8-K Cocrystal Pharma, Inc. For: Feb 18 5.6%
Top News Decliners
10/30 COCRYSTAL PHARMA, INC. ANNOUNCES PROPOSED UNDERWRITTEN PUBLIC OFFERING OF COMMON STOCK -35.5%
3/9 Cocrystal Pharma Announces $6.8 Million Registered Direct Offering Priced At-the-Market -30.7%
11/12 Form 10-Q Cocrystal Pharma, Inc. For: Sep 30 -26.8%
4/22 Form 8-K Cocrystal Pharma, Inc. For: Apr 19 -26.6%
1/29 COCRYSTAL PHARMA, INC. PRICES $2.2 MILLION REGISTERED DIRECT OFFERING -16.9%
3/13 Form 8-K Cocrystal Pharma, Inc. For: Mar 09 -14.8%
2/3 COCRYSTAL PHARMA, INC. ANNOUNCES CLOSING OF $2.2 MILLION REGISTERED DIRECT OFFERING -13.3%
2/27 Cocrystal Pharma Announces $11.0 Million Registered Direct Offering Priced At-the-Market -12.9%
8/9 Form 10-Q Cocrystal Pharma, Inc. For: Jun 30 -12.2%
3/30 Form 8-K Cocrystal Pharma, Inc. For: Mar 30 -10.3%
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.
Click Here To Register For The Live Online Workshop
In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.

Latest Posts

Trading the Google Earnings Announcement: A Strategic Preview
Earnings Week Wrap-up and Takeaways
Earnings Season: Q3 Review, Q4 Kickoff – Morgan Stanley, Bank of America, Goldman Sachs, Netflix
Guerrilla Learning Opportunity: Wealth365 Conference Featuring News Quantified Founder and Much More
The Smart Way to Ten Minutes Per Day

Information

Support

Contact us

20715 N Pima Rd #F108
Scottsdale, AZ 85255
Email: info@newsquantified.com
Copyright Ⓒ News Quanitifed LLC. 1.1.3